Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Tuesday, 13 March 2018

PCI Biotech: Invitation to full year 2017 presentation

PCI Biotech Holding    

Published: 08:00 CET 13-03-2018 /GlobeNewswire /Source: PCI Biotech Holding / : PCIB /ISIN: N00010405640

PCI Biotech: Invitation to full year 2017 presentation

Oslo, 13 March 2018 - PCI Biotech invites to a presentation of the company's full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park.


Time: Tuesday March 20, 08:30am - 09:30am CET (local time).

Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo


The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to post@pcibiotech.com.


The presentation can be followed as a live audiocast from this link (audiocast full year 2017) or under "Webcasts" at the company's webpage www.pcibiotech.com. It will be possible to post questions through the audiocast console.


The presentation will be available on www.newsweb.no and on the company's webpage, www.pcibiotech.com from 07:30am CET on 20 March 2018. The annual report 2017 will be released in a separate stock exchange notice.


For further information, please contact:


Ronny Skuggedal, CFO

Email: rs@pcibiotech.no

Mobile: +47 9400 5757

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: PCI Biotech Holding ASA, Ullernchausséen 64, Oslo 0379, Norway
If you would like to unsubscribe and stop receiving these e-mails click here.